figshare
Browse
1/1
3 files

ECAS A-B-C: alternate forms of the Edinburgh Cognitive and Behavioural ALS Screen

dataset
posted on 2017-12-05, 13:11 authored by Christopher J. Crockford, Michaela Kleynhans, Evelyn Wilton, Ratko Radakovic, Judith Newton, Elaine H. Niven, Ammar Al-Chalabi, Orla Hardiman, Thomas H. Bak, Sharon Abrahams

Background: The Edinburgh Cognitive and Behavioural ALS Screen (ECAS) is a short assessment by which neuropsychological symptoms can be detected and quantified in people with ALS. To avoid potential practice effects with repeated administration, here we present alternative versions of the ECAS suitable for measuring change over time. Objective: To develop two alternate versions of the ECAS: ECAS-B and ECAS-C. Method: One hundred and forty-nine healthy adult participants were recruited. Thirty participants completed a pilot study in developing the alternate versions. Two groups of 40 participants were administered the ECAS-B or ECAS-C and compared to published data of the original ECAS (ECAS-A) to determine equivalence. An additional 39 participants were administered the ECAS consecutively, either repeating the original version (ECAS-A-A-A) serially or the different versions (ECAS-A-B-C) to determine potential practice effects. Recordings of assessments were scored by a second researcher to determine inter-rater reliability. Results: No significant differences were found between versions (A, B, C) of the composite performance measures of ALS Specific, ALS Non-Specific, and ECAS Total scores. Repeated serial administration of ECAS-A (A-A-A) produced some practice effects for composite scores, whereas no such effects were found when alternate versions were administered serially (A-B-C). Exceptionally high intra-class correlations were found for all three versions of the ECAS suggesting a high degree of rater agreement. Conclusion: The newly developed alternate forms of the ECAS are both highly equitable to the original ECAS-A and enable avoidance of practice effects, thus supporting their use in measuring cognition and behaviour over time.

Funding

This work was supported by a grant from the Amyotrophic Lateral Sclerosis Association [ALSA; ID: 179]. The project is supported through the following funding organizations under the aegis of JPND - http://www.jpnd.eu (United Kingdom, Medical Research Council [MR/L501529/1], Economic and Social Research Council [ES/L008238/1], and Irish Health Research Board [HRB-JPND/2013/1]). CC receives support from the Euan MacDonald Centre for Motor Neurone Disease Research. AAC receives salary support from the National Institute for Health Research Maudsley Biomedical Research Centre.

History

Usage metrics

    AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEGENERATION

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC